EUCTR2006-003523-36-GBActive, not recruitingNot Applicable
Magnesium in Aneurysmal Subarachnoid Haemorrhage - MASH-II
etherlands Heart Foundation0 sites1,200 target enrollmentStarted: September 9, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 1,200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Aneurysmal subarachnoid haemorrhage 2. Admission to one of participating hospital within 4 days
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •1. Aged under 18 years 2. Kidney failure (kreatinine > 150 umol/L) 3. Body weight < 50 kg 4. No informed consent obtained
Investigators
Similar Trials
Completed
Phase 3
Magnesium in Aneurysmal Subarachnoid HaemorrhageISRCTN68742385niversity Medical Centre Utrecht (UMCU) (The Netherlands)1,200
Recruiting
Not Applicable
Magnesium in Aneurysmal Subarachnoid Hemorrhage.NL-OMON206701,200
Unknown
Not Applicable
Application of Magnesium-rich Artificial Cerebrospinal Fluid in Aneurysmal Subarachnoid HemorrhageAneurysmal Subarachnoid HemorrhageNCT04358445First Affiliated Hospital Xi'an Jiaotong University70
Not yet recruiting
Phase 2
Magnesium Treating Subarachnoid Hemorrhage VasospasmCerebral VasospasmSubarachnoid Hemorrhage, AneurysmalNCT04613960General Committee of Teaching Hospitals and Institutes, Egypt200
Not yet recruiting
Not Applicable
A study to know the effects of magnesiun sulphate and fentanyl in spinal anesthesia.CTRI/2022/03/041477Mayo institute of medical sciences